Bestudy
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bestudy - overview
Established
2010
Location
Shanghai, -, China
Primary Industry
Pharmaceuticals
About
Established in 2010 and based in Shanghai, China, Bestudy is a medicine company that focuses on clinical drug development. It has been working on projects with over 400 hospitals in more than 30 provinces and 86 cities and established partnerships with Baxter, Bayer, and other companies. The branch offices have been set up in Beijing, Guangzhou, Chengdu, and other places. In September 2020, it raised series B funding for CNY 100 million.
In 2021, Bestudy was selected as a Specialized, Refined, Featured, and Original SME in Shanghai. The company is committed to providing clinical research services to domestic and foreign pharmaceutical and medical equipment enterprises such as registration and application, protocol writing, site screening, clinical monitoring services, and so on for Phase I-IV drug clinical trials and medical device clinical trials. It has participated in the registration and application, clinical design, and project management of over 80 new drugs, and undertook over 500 registered clinical research projects for phases I-III.
Current Investors
CCB Private Equity Investment Management, Huaige Capital, Loyal Valley Capital
Primary Industry
Pharmaceuticals
Sub Industries
Education & Training Services, Pharmaceutical Research & Development
Website
www.bestudycro.com
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.